Magnetic resonance continues to evolve and advance as a critical imaging modality for disease diagnosis and monitoring. Hardware and software advances continue to propel this modality to the forefront of the field of diagnostic imaging. Next generation MR contrast media, specifically gadolinium chelates with improved relaxivity and stability (relative to the provided contrast effect), have emerged providing a further boost to the field. Concern regarding gadolinium deposition in the body with primarily the weaker gadolinium chelates (which have been now removed from the market, at least in Europe) continues to be at the forefront of clinicians' minds. This has driven renewed interest in possible development of manganese-based contrast media. The development of photon counting CT and its clinical introduction have made possible a further major advance in CT image quality, along with the potential for decreasing radiation dose. The possibility of major clinical advances in thoracic, cardiac, and musculoskeletal imaging were first recognized, with its broader impact - across all organ systems - now also recognized. The utility of routine acquisition (without penalty in time or radiation dose) of full spectral multi-energy data is now also being recognized as an additional major advance made possible by photon counting CT. Artificial intelligence is now being used in the background across most imaging platforms and modalities, making possible further advances in imaging technique and image quality, although this field is nowhere yet near to realizing its full potential. And last, but not least, the field of ultrasound is on the cusp of further major advances in availability (with development of very low-cost systems) and a possible new generation of microbubble contrast media.

Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder in which tau neurofibrillary tangles are a pathological hallmark closely associated with cognitive dysfunction and neurodegeneration. In this study, we used brain tau data to investigate AD heterogeneity by identifying and characterizing the subpopulations among patients. We included 615 cognitively normal and 159 AD brain ¹⁸F-flortaucipr PET scans, along with T1-weighted MRI from the Alzheimer Disease Neuroimaging Initiative database. A three dimensional-convolutional neural network model was employed for AD detection using standardized uptake value ratio (SUVR) images. The model-derived saliency maps were generated and employed as informative image features for clustering AD participants. Among the identified subpopulations, statistical analysis of demographics, neuropsychological measures, and SUVR were compared. Correlations between neuropsychological measures and regional SUVRs were assessed. A generalized linear model was utilized to investigate the sex and APOE ε4 interaction effect on regional SUVRs. Two distinct subpopulations of AD patients were revealed, denoted as S_Hi and S_Lo. Compared to the S_Lo group, the S_Hi group exhibited a significantly higher global tau burden in the brain, but both groups showed similar cognition distribution levels. In the S_Hi group, the associations between the neuropsychological measurements and regional tau deposition were weakened. Moreover, a significant interaction effect of sex and APOE ε4 on tau deposition was observed in the S_Lo group, but no such effect was found in the S_Hi group. Our results suggest that tau tangles, as shown by SUVR, continue to accumulate even when cognitive function plateaus in AD patients, highlighting the advantages of PET in later disease stages. The differing relationships between cognition and tau deposition, and between gender, APOE4, and tau deposition, provide potential for subtype-specific treatments. Targeting gender-specific and genetic factors influencing tau deposition, as well as interventions aimed at tau's impact on cognition, may be effective.

Medical reports, particularly radiology findings, are often written for professional communication, making them difficult for patients to understand. This communication barrier can reduce patient engagement and lead to misinterpretation. Artificial intelligence (AI), especially large language models such as ChatGPT, offers new opportunities for simplifying medical documentation to improve patient comprehension. We aimed to evaluate whether AI-generated radiology reports simplified by ChatGPT improve patient understanding, readability, and communication quality compared to original AI-generated reports. In total, 3 versions of radiology reports were created using ChatGPT: an original AI-generated version (text 1), a patient-friendly, simplified version (text 2), and a further simplified and accessibility-optimized version (text 3). A total of 300 patients (n=100, 33.3% per group), excluding patients with medical education, were randomly assigned to review one text version and complete a standardized questionnaire. Readability was assessed using the Flesch Reading Ease (FRE) score and LIX indices. Both simplified texts showed significantly higher readability scores (text 1: FRE score=51.1; text 2: FRE score=55.0; and text 3: FRE score=56.4; P<.001) and lower LIX scores, indicating enhanced clarity. Text 3 had the shortest sentences, had the fewest long words, and scored best on all patient-rated dimensions. Questionnaire results revealed significantly higher ratings for texts 2 and 3 across clarity (P<.001), tone (P<.001), structure, and patient engagement. For example, patients rated the ability to understand findings without help highest for text 3 (mean 1.5, SD 0.7) and lowest for text 1 (mean 3.1, SD 1.4). Both simplified texts significantly improved patients' ability to prepare for clinical conversations and promoted shared decision-making. AI-generated simplification of radiology reports significantly enhances patient comprehension and engagement. These findings highlight the potential of ChatGPT as a tool to improve patient-centered communication. While promising, future research should focus on ensuring clinical accuracy and exploring applications across diverse patient populations to support equitable and effective integration of AI in health care communication.

The integration of large language models (LLMs) into medical diagnostics has garnered substantial attention due to their potential to enhance diagnostic accuracy, streamline clinical workflows, and address health care disparities. However, the rapid evolution of LLM research necessitates a comprehensive synthesis of their applications, challenges, and future directions. This scoping review aimed to provide an overview of the current state of research regarding the use of LLMs in medical diagnostics. The study sought to answer four primary subquestions, as follows: (1) Which LLMs are commonly used? (2) How are LLMs assessed in diagnosis? (3) What is the current performance of LLMs in diagnosing diseases? (4) Which medical domains are investigating the application of LLMs? This scoping review was conducted according to the Joanna Briggs Institute Manual for Evidence Synthesis and adheres to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Relevant literature was searched from the Web of Science, PubMed, Embase, IEEE Xplore, and ACM Digital Library databases from 2022 to 2025. Articles were screened and selected based on predefined inclusion and exclusion criteria. Bibliometric analysis was performed using VOSviewer to identify major research clusters and trends. Data extraction included details on LLM types, application domains, and performance metrics. The field is rapidly expanding, with a surge in publications after 2023. GPT-4 and its variants dominated research (70/95, 74% of studies), followed by GPT-3.5 (34/95, 36%). Key applications included disease classification (text or image-based), medical question answering, and diagnostic content generation. LLMs demonstrated high accuracy in specialties like radiology, psychiatry, and neurology but exhibited biases in race, gender, and cost predictions. Ethical concerns, including privacy risks and model hallucination, alongside regulatory fragmentation, were critical barriers to clinical adoption. LLMs hold transformative potential for medical diagnostics but require rigorous validation, bias mitigation, and multimodal integration to address real-world complexities. Future research should prioritize explainable artificial intelligence frameworks, specialty-specific optimization, and international regulatory harmonization to ensure equitable and safe clinical deployment.

Multimodal large language models (MLLMs) have shown great potential in general domains but perform poorly in some specific domains due to a lack of domain-specific data, such as image-text data or vedio-text data. In some specific domains, there is abundant graphic and textual data scattered around, but lacks standardized arrangement. In the field of medical ultrasound, there are ultrasonic diagnostic books, ultrasonic clinical guidelines, ultrasonic diagnostic reports, and so on. However, these ultrasonic materials are often saved in the forms of PDF, images, etc., and cannot be directly used for the training of MLLMs. This paper proposes a novel image-text reasoning supervised fine-tuning data generation pipeline to create specific domain quadruplets (image, question, thinking trace, and answer) from domain-specific materials. A medical ultrasound domain dataset ReMUD is established, containing over 45,000 reasoning and non-reasoning supervised fine-tuning Question Answering (QA) and Visual Question Answering (VQA) data. The ReMUD-7B model, fine-tuned on Qwen2.5-VL-7B-Instruct, outperforms general-domain MLLMs in medical ultrasound field. To facilitate research, the ReMUD dataset, data generation codebase, and ReMUD-7B parameters will be released at https://github.com/ShiDaizi/ReMUD, addressing the data shortage issue in specific domain MLLMs.

Lung cancer remains one of the most prevalent and fatal diseases worldwide, demanding accurate and timely diagnosis and treatment. Recent advancements in large AI models have significantly enhanced medical image understanding and clinical decision-making. This review systematically surveys the state-of-the-art in applying large AI models to lung cancer screening, diagnosis, prognosis, and treatment. We categorize existing models into modality-specific encoders, encoder-decoder frameworks, and joint encoder architectures, highlighting key examples such as CLIP, BLIP, Flamingo, BioViL-T, and GLoRIA. We further examine their performance in multimodal learning tasks using benchmark datasets like LIDC-IDRI, NLST, and MIMIC-CXR. Applications span pulmonary nodule detection, gene mutation prediction, multi-omics integration, and personalized treatment planning, with emerging evidence of clinical deployment and validation. Finally, we discuss current limitations in generalizability, interpretability, and regulatory compliance, proposing future directions for building scalable, explainable, and clinically integrated AI systems. Our review underscores the transformative potential of large AI models to personalize and optimize lung cancer care.

MRI, as a mature diagnostic method in clinical application, is favored by doctors and patients, there are also insurmountable bottleneck problems. AI strategies such as multimodal imaging integration and machine learning are used to build an intelligent multimodal imaging system based on MRI data to solve the unmet clinical needs in various medical environments. This review systematically discusses the development of MRI-guided multimodal imaging systems and the application of intelligent multimodal imaging systems integrated with artificial intelligence in the early diagnosis of brain and cardiovascular diseases. The safe and effective deployment of AI in clinical diagnostic equipment can help enhance early accurate diagnosis and personalized patient care.

Brain tumors, regardless of being benign or malignant, pose considerable health risks, with malignant tumors being more perilous due to their swift and uncontrolled proliferation, resulting in malignancy. Timely identification is crucial for enhancing patient outcomes, particularly in nations such as Bangladesh, where healthcare infrastructure is constrained. Manual MRI analysis is arduous and susceptible to inaccuracies, rendering it inefficient for prompt diagnosis. This research sought to tackle these problems by creating an automated brain tumor classification system utilizing MRI data obtained from many hospitals in Bangladesh. Advanced deep learning models, including VGG16, VGG19, and ResNet50, were utilized to classify glioma, meningioma, and various brain cancers. Explainable AI (XAI) methodologies, such as Grad-CAM and Grad-CAM++, were employed to improve model interpretability by emphasizing the critical areas in MRI scans that influenced the categorization. VGG16 achieved the most accuracy, attaining 99.17%. The integration of XAI enhanced the system's transparency and stability, rendering it more appropriate for clinical application in resource-limited environments such as Bangladesh. This study highlights the capability of deep learning models, in conjunction with explainable artificial intelligence (XAI), to enhance brain tumor detection and identification in areas with restricted access to advanced medical technologies.

The growing integration of vision-language models (VLMs) in medical applications offers promising support for diagnostic reasoning. However, current medical VLMs often face limitations in generalization, transparency, and computational efficiency-barriers that hinder deployment in real-world, resource-constrained settings. To address these challenges, we propose a Reasoning-Aware Reinforcement Learning framework, \textbf{RARL}, that enhances the reasoning capabilities of medical VLMs while remaining efficient and adaptable to low-resource environments. Our approach fine-tunes a lightweight base model, Qwen2-VL-2B-Instruct, using Low-Rank Adaptation and custom reward functions that jointly consider diagnostic accuracy and reasoning quality. Training is performed on a single NVIDIA A100-PCIE-40GB GPU, demonstrating the feasibility of deploying such models in constrained environments. We evaluate the model using an LLM-as-judge framework that scores both correctness and explanation quality. Experimental results show that RARL significantly improves VLM performance in medical image analysis and clinical reasoning, outperforming supervised fine-tuning on reasoning-focused tasks by approximately 7.78%, while requiring fewer computational resources. Additionally, we demonstrate the generalization capabilities of our approach on unseen datasets, achieving around 27% improved performance compared to supervised fine-tuning and about 4% over traditional RL fine-tuning. Our experiments also illustrate that diversity prompting during training and reasoning prompting during inference are crucial for enhancing VLM performance. Our findings highlight the potential of reasoning-guided learning and reasoning prompting to steer medical VLMs toward more transparent, accurate, and resource-efficient clinical decision-making. Code and data are publicly available.

The Segment Anything Model (SAM) was fine-tuned on the EchoNet-Dynamic dataset and evaluated on external transthoracic echocardiography (TTE) and Point-of-Care Ultrasound (POCUS) datasets from CAMUS (University Hospital of St Etienne) and Mayo Clinic (99 patients: 58 TTE, 41 POCUS). Fine-tuned SAM was superior or comparable to MedSAM. The fine-tuned SAM also outperformed EchoNet and U-Net models, demonstrating strong generalization, especially on apical 2-chamber (A2C) images (fine-tuned SAM vs. EchoNet: CAMUS-A2C: DSC 0.891 ± 0.040 vs. 0.752 ± 0.196, p < 0.0001) and POCUS (DSC 0.857 ± 0.047 vs. 0.667 ± 0.279, p < 0.0001). Additionally, SAM-enhanced workflow reduced annotation time by 50% (11.6 ± 4.5 sec vs. 5.7 ± 1.7 sec, p < 0.0001) while maintaining segmentation quality. We demonstrated an effective strategy for fine-tuning a vision foundation model for enhancing clinical workflow efficiency and supporting human-AI collaboration.